CROMSOURCE

Executive Summary

CROMSOURCE (operating as ClinChoice) is a well-established, full-service global Contract Research Organization (CRO) founded in 1995 and headquartered in Raleigh, North Carolina. The company specializes in accelerating drug and device approvals for biopharmaceutical and medical device clients, with a particular focus on complex therapeutic areas including Oncology, Rare Disease, and Neuroscience. By providing comprehensive clinical development services, CROMSOURCE plays a critical role in bringing innovative therapies to market, contributing to a safer and better world. As a private company with over 25 years of experience, CROMSOURCE has built a reputation for expertise in regulatory affairs, clinical monitoring, data management, and biostatistics. The company's ability to navigate the increasing complexity of clinical trials positions it well for sustained growth, driven by rising R&D outsourcing trends and the growing demand for specialized drug development services.

Upcoming Catalysts (preview)

• Q3 2026Major contract win in oncology or rare disease60% success
• Q4 2026Expansion into new geographic markets (e.g., Asia-Pacific)50% success
• TBDStrategic acquisition or partnership to enhance capabilities40% success